RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Trinity Biotech ROA 2024

Trinity Biotech ROA

-0.4

Trinity Biotech Dividend yield

14.38 %

Ticker

TRIB

ISIN

US8964383066

WKN

A0ET3S

In 2024, Trinity Biotech's return on assets (ROA) was -0.4, a -9.22% increase from the -0.45 ROA in the previous year.

Trinity Biotech Aktienanalyse

What does Trinity Biotech do?

Trinity Biotech PLC is a company specialized in the development, production, and marketing of diagnostic tests for infectious diseases, autoimmune diseases, and cancer. The company was founded in 1992 by Ronan O'Caoimh, an experienced manager in the diagnostics industry. Trinity Biotech has continuously expanded its business and is now recognized as one of the leading companies in the industry worldwide. Its business strategy is based on the development and marketing of diagnostic tests utilizing the latest technology and research. The company has a strong focus on continuous research and development of new products and technologies. Trinity Biotech operates in three main divisions: infectious diseases, autoimmune diseases, and cancer diagnostics. The company offers tests for various infectious diseases such as HIV, hepatitis, and tuberculosis in the infectious diseases division. The autoimmune diseases division develops and produces diagnostic tests for autoimmune diseases such as lupus, rheumatoid arthritis, and Sjögren's syndrome. The cancer diagnostics division offers tests for various types of cancer such as breast cancer, prostate cancer, and colon cancer. Trinity Biotech's key products include the Uni-Gold HIV test, the TrinScreen Hepatitis C test, and the Uni-Gold S. pneumoniae test. These tests are highly accurate and reliable diagnostic tools used by clinics and laboratories worldwide. Trinity Biotech has a global presence with offices in North America, Europe, Asia, and the Middle East. The company is committed to providing its customers with the best possible diagnostic technology and support. Overall, Trinity Biotech is a renowned company in the diagnostics industry focused on developing innovative diagnostic tests for infectious diseases, autoimmune diseases, and cancer. With its strong R&D department, wide range of products, and global presence, Trinity Biotech will continue to play a leading role in the industry. Trinity Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Trinity Biotech's Return on Assets (ROA)

Trinity Biotech's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Trinity Biotech's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Trinity Biotech's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Trinity Biotech’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Trinity Biotech Stock

What is the Return on Assets (ROA) of Trinity Biotech this year?

The Return on Assets (ROA) of Trinity Biotech is -0.4 undefined this year.

What was the ROA of Trinity Biotech compared to the previous year?

The ROA of Trinity Biotech has increased by -9.22% compared to the previous year.

What consequences do high ROA have for investors of Trinity Biotech?

A high ROA is advantageous for investors of Trinity Biotech, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Trinity Biotech?

A low ROA can be unfavorable for investors of Trinity Biotech as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Trinity Biotech affect the company?

An increase in ROA of Trinity Biotech can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Trinity Biotech impact the company?

A reduction in the ROA of Trinity Biotech can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Trinity Biotech?

Some factors that can influence the ROA of Trinity Biotech include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Trinity Biotech important for investors?

The ROA of Trinity Biotech is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Trinity Biotech take to improve ROA?

To improve ROA, Trinity Biotech can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Trinity Biotech pay?

Over the past 12 months, Trinity Biotech paid a dividend of 0.22 USD . This corresponds to a dividend yield of about 14.38 %. For the coming 12 months, Trinity Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Trinity Biotech?

The current dividend yield of Trinity Biotech is 14.38 %.

When does Trinity Biotech pay dividends?

Trinity Biotech pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Trinity Biotech?

Trinity Biotech paid dividends every year for the past 1 years.

What is the dividend of Trinity Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Trinity Biotech located?

Trinity Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Trinity Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Trinity Biotech from 7/1/2015 amounting to 0.22 USD, you needed to have the stock in your portfolio before the ex-date on 6/5/2015.

When did Trinity Biotech pay the last dividend?

The last dividend was paid out on 7/1/2015.

What was the dividend of Trinity Biotech in the year 2023?

In the year 2023, Trinity Biotech distributed 0 USD as dividends.

In which currency does Trinity Biotech pay out the dividend?

The dividends of Trinity Biotech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Trinity Biotech stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Trinity Biotech

Our stock analysis for Trinity Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Trinity Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.